Shenzhen NewDEL Biotech, Co., Ltd
2 clinical trials · Sponsor
◉ Watch Shenzhen NewDEL Biotech, Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety, Tolerability and Pharmacokinetic of ND-003 Tablets in Healthy Adults (NCT06360874) | Shenzhen NewDEL Biotech, Co., Ltd | 2024-05-09 |
| An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers (NCT06169579) | Shenzhen NewDEL Biotech, Co., Ltd | 2024-02-04 |
Track Shenzhen NewDEL Biotech, Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.